Fig. 1
From: YY1: a key regulator inhibits gastric cancer ferroptosis and mediating apatinib-resistance
High expression of YY1 related to poor GC prognosis. (A and B) TCGA data showed that patients with high YY1 levels have significantly lower postoperative PFS [HR = 1.39 (0.98 − 1.98), * p = 0.065] and DSS [HR = 1.99 (1.31 − 3.02), **p < 0.01) rates. (C and D) Multivariate analysis showed YY1 expression status and correlation with DSS [HR = 1.84 (1.16, 2.91), **p < 0.01]